Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

PURPOSE: Primary endocrine therapy for ductal carcinoma in situ (DCIS) as a potential alternative to surgery has been understudied. This trial explored the feasibility of a short-term course of letrozole and sought to determine whether treatment results in measurable radiographic and biologic change...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Hwang, E. Shelley, Hyslop, Terry, Hendrix, Laura H., Duong, Stephanie, Bedrosian, Isabelle, Price, Elissa, Caudle, Abigail, Hieken, Tina, Guenther, Joseph, Hudis, Clifford A., Winer, Eric, Lyss, Alan P., Dickson-Witmer, Diana, Hoefer, Richard, Ollila, David W., Hardman, Timothy, Marks, Jeffrey, Chen, Yunn-Yi, Krings, Gregor, Esserman, Laura, Hylton, Nola
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2020
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164489/
https://ncbi.nlm.nih.gov/pubmed/32125937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00510
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky